2015
DOI: 10.3402/jev.v4.26048
|View full text |Cite
|
Sign up to set email alerts
|

Potentials and capabilities of the Extracellular Vesicle (EV) Array

Abstract: Extracellular vesicles (EVs) and exosomes are difficult to enrich or purify from biofluids, hence quantification and phenotyping of these are tedious and inaccurate. The multiplexed, highly sensitive and high-throughput platform of the EV Array presented by Jørgensen et al., (J Extracell Vesicles, 2013; 2: 10) has been refined regarding the capabilities of the method for characterization and molecular profiling of EV surface markers. Here, we present an extended microarray platform to detect and phenotype plas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
61
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 71 publications
(64 citation statements)
references
References 12 publications
3
61
0
Order By: Relevance
“…Additionally, the EV array might be an interesting alternative for future studies. 40 Although we have shown many important advances in EVs' labeling and imaging, many questions are still needed to be answered in future studies. We have shown that labeling of hBM-MSCs with PKH26 or Molday ION is an effective way to isolate labeled EVs from them.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, the EV array might be an interesting alternative for future studies. 40 Although we have shown many important advances in EVs' labeling and imaging, many questions are still needed to be answered in future studies. We have shown that labeling of hBM-MSCs with PKH26 or Molday ION is an effective way to isolate labeled EVs from them.…”
mentioning
confidence: 99%
“…Interestingly, Molday ION was uniformly distributed inside the EVs in our study, while the nonfluorescent USPIO nanoparticles reported by others looked rather clumped. 40 Further studies to investigate if such difference in intravesicular distribution affects their therapeutic potential are warranted.…”
mentioning
confidence: 99%
“…After the detection of p53 in exosomes that were secreted at least by one cell line, we decided to test whether it is possible to detect this protein in exosomes of human body fluids, e.g., to confirm its presence in exosomes of blood plasma (Jorgensen et al, 2015). Immunoblotting has not given a positive result: no p53 was observed in exosomes of blood plasma.…”
Section: Resultsmentioning
confidence: 99%
“…Some authors believe that p53 can enhance the secretion of exosomes by activating the transcription of several genes that are involved in their production (Yu et al, 2006;Lespagnol et al, 2008;Naghibalhossaini et al, 2011;Lim et al, 2012). However, to date, p53 has not been found in exosomes that are secreted by cell lines (Kalra et al, 2012;Keerthikumar et al, 2015), with only one study demonstrating its presence in exosomes of human blood plasma (Jorgensen et al, 2015). Thus, this problem requires a more detailed study.…”
Section: Introductionmentioning
confidence: 99%
“…A recent example applied to EV is the "EV array" [21,22]. The EV array utilizes slides printed with an array of antibodies to capture EV and then determines the amount of captured EV by labeling with a cocktail of biotinylated CD9, CD63 and CD81 and the use of streptavidin-Cy5 as a reporter molecule.…”
Section: C3 Fluorescent Immunosorbent Assay (Flisa)mentioning
confidence: 99%